Login / Signup

Freezing of Gait in Parkinson's Disease Patients Treated with Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Long-Term Overview.

Giulia Di RausoFrancesco CavallieriIsabella CampaniniAnnalisa GessaniValentina FioravantiAlberto FelettiBenedetta DamianoSara ScaltritiElisa BardiMaria Giulia CorniFrancesca AntonelliVittorio RispoliFrancesca CavalleriMaria Angela MolinariSara ContardiElisa MenozziAnnette PuzzolanteJessica RossiStefano MelettiGiuseppe BiaginiGiacomo PavesiValerie FraixMirco LusuardiAlessandro FraternaliAnnibale VersariCarla BudriesiElena F MoroAndrea MerloFranco Valzania
Published in: Biomedicines (2022)
Bilateral subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment in advanced Parkinson's Disease (PD). However, the effects of STN-DBS on freezing of gait (FOG) are still debated, particularly in the long-term follow-up (≥5-years). The main aim of the current study is to evaluate the long-term effects of STN-DBS on FOG. Twenty STN-DBS treated PD patients were included. Each patient was assessed before surgery through a detailed neurological evaluation, including FOG score, and revaluated in the long-term (median follow-up: 5-years) in different stimulation and drug conditions. In the long term follow-up, FOG score significantly worsened in the off-stimulation/off-medication condition compared with the pre-operative off-medication assessment (z = -1.930; p = 0.05) but not in the on-stimulation/off-medication (z = -0.357; p = 0.721). There was also a significant improvement of FOG at long-term assessment by comparing on-stimulation/off-medication and off-stimulation/off-medication conditions (z = -2.944; p = 0.003). These results highlight the possible beneficial long-term effects of STN-DBS on FOG.
Keyphrases
  • deep brain stimulation
  • parkinson disease
  • obsessive compulsive disorder
  • adverse drug
  • healthcare
  • case report
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • minimally invasive
  • prognostic factors